# Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation

> **NCT02399735** · PHASE1 · UNKNOWN · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University** · enrollment: 18 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **BIOLOGICAL:** Low Dose NK cells ×4 times
- **BIOLOGICAL:** Normal Dose NK cells ×4 times
- **BIOLOGICAL:** Normal Dose NK cells ×8 times

## Key facts

- **NCT ID:** NCT02399735
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2016-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02399735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02399735, "Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02399735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*